lipidil
abbott laboratÓrios do brasil ltda - fenofibrato - antilipemicos
fenofibrato
abbott laboratÓrios do brasil ltda - fenofibrato - antilipemicos
entocort
biolab sanus farmacÊutica ltda - budesonida micronizada - glicocorticoides top. simp. exc. uso oftalm.
allenasal
sanofi medley farmacÊutica ltda. - acetonida de triancinolona - glicocorticoides sistemicos
selit
opem representaÇÃo importadora exportadora e distribuidora ltda - selenito dissódico pentaidratado - outros prods nao enquadrados em classe terapeutica especif
edluar 5 mg comprimido sublingual
bgp products, unipessoal lda. - zolpidem - comprimido sublingual - 5 mg - zolpidem, tartarato 5 mg - zolpidem - n/a - duração do tratamento: curta ou média duração
edluar 10 mg comprimido sublingual
bgp products, unipessoal lda. - zolpidem - comprimido sublingual - 10 mg - zolpidem, tartarato 10 mg - zolpidem - n/a - duração do tratamento: curta ou média duração
edluar 10 mg comprimido sublingual
bgp products, unipessoal lda. - zolpidem - comprimido sublingual - 10 mg - zolpidem, tartarato 10 mg - zolpidem - n/a - duração do tratamento: curta ou média duração
edluar 5 mg comprimido sublingual
bgp products, unipessoal lda. - zolpidem - comprimido sublingual - 5 mg - zolpidem, tartarato 5 mg - zolpidem - n/a - duração do tratamento: curta ou média duração
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.